Ajooni Biotech Limited has informed the Exchange regarding 'Submission of Confirmation Certificate as per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the Quarter Ended on 31st December, 2025.'.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajooni Biotech has submitted a routine compliance certificate to NSE for the quarter ended 31 December 2025. The certificate was issued by its Registrar and Transfer Agent, Cameo Corporate Services Limited, confirming that all share dematerialization requests received from depository participants during the October–December 2025 quarter were properly processed. It also confirms that the underlying securities are listed on the stock exchanges, physical certificates were cancelled after verification, and the depository's name was entered in the company's register of members within the timeline required by SEBI rules. There are no financial numbers, business updates, or corporate actions mentioned in this filing.
This is a standard, procedural compliance filing required every quarter and carries no material impact on the company's financials, operations, or share price. Retail investors can safely treat this as routine housekeeping.